Yes I told him he was incorrectly listed as President of Radient on Bloomberg.
But I doubt he cares. Nobody with market savvy takes the RXPC page on Bloomberg seriously. RXPC doesn't come up in a ticker search on Bloomberg and when you do manage to find their RXPC page by first finding the German page, it shows the O/S as 1.35 billion:
In conclusion: An investor would have to be remarkably naïve to believe the Bloomberg information about Radient. Unfortunately, for those naïve few, the internet contains all kinds of misleading and false stock information.
I choose to believe SEC filings, which means I believe Radient is insolvent, RXPC shares are revoked, and the only Officers and Board Members are the four Australians. I also believe the lack of Schedule 13's proves there is no takeover. But, SEC filings are not for everyone -- they prove too confusing for some.
'Twas ever thus.
Incidentally, if you doubt the validity of MacLellan's email response, ask him yourself. I'm sure he will answer. I think he is eager to distance himself from Radient Pharmaceuticals. As for Mr. Charter responding -- unlikely, IMO.